Top Tweets for #Estro25
@cristian_udo the went on to compare 2 and 5 fraction #SBRT to #brachy monotherapy. The results were mind blowing 🤯
Presented at #ESTRO25 and currently under review (can’t say where)
Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer
https://t.co/mWEo84bs0q
This individual patient data meta-analysis of four prospective trials compared two-fraction versus five-fraction stereotactic body radiotherapy ☢️for intermediate-risk #ProstateCancer and found no meaningful differences in long-term outcomes. With a median follow-up of 9.4 years, biochemical failure, distant metastasis rates, and patient-reported urinary and bowel quality of life were comparable between the two approaches.
Despite the non-randomized design, these results provide the first prospective evidence suggesting that ultra-hypofractionated two-fraction SBRT may offer similar efficacy and tolerability to five-fraction SBRT, supporting its potential role as a standard-of-care option for appropriately selected patients with intermediate-risk prostate cancer.
@cristian_udo
@jaydetsky
@DrStanLiu
@gerard_morton
@dr_vesi
@weeloonong
Andrea Deabreu
@Sunnybrook
@DrAndrewLoblaw
@OncoAlert 🚨
@silkegillessen
@AOmlin
@weoncologists
@Larvol is an incredible resource, no question. But don’t sleep on #ESTRO25!
https://t.co/4a5YvRJstj
Plan your 2025 conference schedule better with @Larvol.
Here is our list of the Top 25 Oncology Conferences worldwide. Explore more about oncology conferences, top trials, and reactions from oncologists: https://t.co/ct6tMIQHii
#LARVOL #Oncology #CancerResearch #CancerData #CancerCare #OncologyUpdates #OncologyConferences #OncologyInsights #GI25 #GU25 #ASCO25 #EHA25 #AACR25 #ESMO25 #SITC25 #ASH25 #SABCS25 #2025Events #MedicalConferences
The conferences: @ASCO | @ASH_hematology | @SABCSSanAntonio | @EHA_Hematology | @myESMO | @sitcancer | @IASLC | @SocietyofHemOnc | @AACR
@Larvol Couldn’t see #ESTRO25 in Vienna 🇦🇹
May 2-6, 2025
➡️ Total participants: Approx 7000
➡️ Countries represented: >80
➡️ Participants: radiation oncologists, medical physicists, radiobiologists, and other healthcare professionals
@ESTRO_RT @Mat_Guc @AnnaKirby17
@brunolarvol
✨The #ESTRO25 Congress Report is out!
📌Green Journal/@TheLancetOncol joint session
📌Award-winning papers
📌Track & technique highlights
👉https://t.co/Md7FkjD9mi
Will your study appear in the report next year? ✅Submit your abstract by 12 Nov! #ESTRO26 https://t.co/xJBUgWNgtj
At #ESTRO25, the RTT pre-meeting course empowered RTTs to lead, collaborate, and innovate in clinical research.
Discover how this dynamic course built skills, confidence, and a research-driven community.
👉 https://t.co/2L4yjCDWeM
#RTTsInResearch #RadiationTherapy #RTT
Lung Breakthroughs at ESTRO25
@ESTRO_RT @Valeriadionisi
https://t.co/MQngPbwBYD
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #ESTRO25 @CancerWorldmag
🚨 #Lungcancer breakthroughs at #ESTRO25!
From osimertinib after chemoRT in unresectable EGFR-mutant NSCLC to #SBRT dose precision and ctDNA insights post-SABR, the lung sessions delivered key updates on optimising treatment and tracking response.
👉 https://t.co/fncBk2o6Ci
Can we move beyond rigid margins and binary targets in radiotherapy? Probabilistic approaches are redefining treatment planning: more accurate, personalised & robust.
💡 Explore the key concepts contained in the latest ICRU report presented at #ESTRO25:
👉 https://t.co/3TR0AnCafV
⚡ From physics to preclinical trials, #FLASH #radiotherapy took the spotlight at #ESTRO25.
Discover the breakthroughs, unanswered questions, & bold steps toward clinical implementation:
👉https://t.co/znlt8UQ2pf
Reirradiation report 5/5: from new RTT-led roles to #brachytherapy breakthroughs and next-gen approaches like #FLASH & carbon ions, #ESTRO25 showcased how #reirradiation is reshaping cancer care.
👉 https://t.co/poprhEfpTF
#radonc
#ESTRO25 Reirradiation Report 4/5: #lungcancer
From beam-angle optimisation with EQD2 integration to inter-centre QA and real-world survival data: explore how dosimetry, image registration, and SBRT are shaping curative reirradiation in thoracic tumours:
👉https://t.co/xQrgtO6QMi
🏆 EMBRACE II won the Donal Hollywood Award at #ESTRO25!
Prof Richard Pötter presented the landmark study’s final results on behalf of the EMBRACE Collaborative Group, setting a new standard for IGRT-IMRT + cisplatin + MR-IGABT in #cervicalcancer.
👉 https://t.co/nETaox2NRb
What’s next for image guidance in RT? From CBCT upgrades and MR integration to tattoo-free SGRT, the field is evolving fast:
✅ Adaptive replanning
✅ AI-powered workflows
✅ Functional imaging.
👉Highlights from the #ESTRO25 teaching lecture: https://t.co/sBDAQ3Acvb
🏆 Best Radiobiology Paper | #ESTRO25
RAD54L & PSMC3IP: key drivers of #DNArepair, stemness & #radioresistance in #HNSCC.
Findings suggest new synthetic lethality with PARP inhibitors.
👉 https://t.co/6PIDTGTq4S
🔥 Should we move away from elective nodal irradiation in #HeadAndNeckCancer? A lively debate at #ESTRO25 explored tradition vs innovation, weighing toxicity, recurrence, and risk-adapted strategies.
👉 Read the debate summary: https://t.co/SLLnU7MzC7
#Radonc #radiotherapy
🏆 Award-winning innovation at #ESTRO25!
The ESTRO-Elekta Brachytherapy Award went to a study that had used electromagnetic tracking to prevent patient mix-ups in breast #brachytherapy — 99.7% correct classification, 0% false positives.
👉 https://t.co/e4Jxi4YQsm
#Radiotherapy
How is #reirradiation used in practice? New insights from #ESTRO25 sessions highlight patterns, outcomes & safety from real-world data:
🔹 ReCare study (multi-site)
🔹 RE-START registry (prostate)
👉 Read the Reirradiation report 3/5: https://t.co/KOi5gfT5kJ #radiotherapy #radonc
From AI-driven planning to immuno combos & HDR vs. LDR debates, the #ESTRO25 #Brachytherapy Track was packed with #innovation.
Explore the latest in research, techniques & teamwork shaping #prostatecancer treatment.
👉 https://t.co/hgsw82w0xW
#ESTRO25 reirradiation report 2/5:
How do physics & biology guide safe, effective #reirradiation? From EQD2 to dose accumulation challenges, the focus group explores:
✅ Planning
✅ Radiobiological modelling
✅ Workflows
💡 Tools & guidelines:
👉 https://t.co/8wifynFmKL #radonc
Insights from the RTT track at European Society for Radiotherapy and Oncology (@ESTRO_RT) 2025
https://t.co/ZbBXTKXLyI
#Cancer #Oncology #ESTRO25 #OncoDaily #Health #Medicine @CancerWorldmag
Last Seen Hashtags on Sotwe
ninfeta filter:videos
Seen from Portugal
First_timers
Seen from Ireland
gaymovie
Seen from Turkey
拉拉
Seen from United States
nsfwtwt
Seen from Egypt
teeNager
Seen from Germany
كحاب_بغداد
Seen from France
nolimits(**)******************************************************
Seen from United States
shota
Seen from Canada
sasuke #hentai
Seen from Germany
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.2M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.8M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
89M followers
Taylor Swift
@taylorswift13
82.9M followers
Lady Gaga
@ladygaga
74.4M followers
Virat Kohli
@imvkohli
71.9M followers
Kim Kardashian
@kimkardashian
70.4M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
64.8M followers
Bill Gates
@billgates
64.6M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers